[go: up one dir, main page]

CN114392492A - Intelligent nondestructive phototherapy system - Google Patents

Intelligent nondestructive phototherapy system Download PDF

Info

Publication number
CN114392492A
CN114392492A CN202210003888.9A CN202210003888A CN114392492A CN 114392492 A CN114392492 A CN 114392492A CN 202210003888 A CN202210003888 A CN 202210003888A CN 114392492 A CN114392492 A CN 114392492A
Authority
CN
China
Prior art keywords
eye information
treatment parameter
module
preset
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202210003888.9A
Other languages
Chinese (zh)
Other versions
CN114392492B (en
Inventor
周非凡
宋瑞祥
顾晓彤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hainan University
Original Assignee
Hainan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hainan University filed Critical Hainan University
Priority to CN202210003888.9A priority Critical patent/CN114392492B/en
Publication of CN114392492A publication Critical patent/CN114392492A/en
Application granted granted Critical
Publication of CN114392492B publication Critical patent/CN114392492B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/11Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for measuring interpupillary distance or diameter of pupils
    • A61B3/112Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for measuring interpupillary distance or diameter of pupils for measuring diameter of pupils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0626Monitoring, verifying, controlling systems and methods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0635Radiation therapy using light characterised by the body area to be irradiated
    • A61N2005/0643Applicators, probes irradiating specific body areas in close proximity
    • A61N2005/0645Applicators worn by the patient
    • A61N2005/0647Applicators worn by the patient the applicator adapted to be worn on the head

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Radiation-Therapy Devices (AREA)

Abstract

本发明公开一种智能化无损光疗系统,光疗系统包括:监控模块、处理模块和光疗模块;监控模块获取患者的第一眼部信息和第二眼部信息;处理模块根据获取到的第一眼部信息和第二眼部信息,生成患者眼部当前的变化参数;根据变化参数、当前的第一治疗参数和预设的调整幅度,生成第二治疗参数;光疗模块根据接收到的第二治疗参数调整治疗光源的光照剂量。应用本发明的光疗系统的治疗对患者身体无任何副作用。

Figure 202210003888

The invention discloses an intelligent non-destructive phototherapy system. The phototherapy system comprises: a monitoring module, a processing module and a phototherapy module; the monitoring module obtains first eye information and second eye information of a patient; According to the change parameter, the current first treatment parameter and the preset adjustment range, the second treatment parameter is generated; the phototherapy module is based on the received second treatment The parameter adjusts the light dose of the treatment light source. The treatment using the phototherapy system of the present invention does not have any side effects on the patient's body.

Figure 202210003888

Description

一种智能化无损光疗系统An intelligent nondestructive phototherapy system

技术领域technical field

本发明涉及生命健康技术领域,具体而言,涉及一种智能化无损光疗系统。The invention relates to the technical field of life and health, in particular to an intelligent nondestructive phototherapy system.

背景技术Background technique

神经退行性疾病(Neurodegenerative diseases,NDs)是一种常见的慢性增龄性疾病,影响中枢神经系统和周围神经系统,其特征是以前完整的神经功能不可逆、进行性丧失,并随着年龄的增长而恶化,包括阿尔茨海默病(Alzheimer diseases,ADs)、帕金森病(Parkinson’s disease,PDs)等。目前,ND的主要治疗方法是药剂学,但现有的药物只能缓解症状,且有副作用,如腹泻、恶心、头痛等。此外,针对ND的病情特点,治疗不局限于医疗机构,更重要的是日常的居家护理。Neurodegenerative diseases (NDs) are common chronic ageing diseases that affect the central and peripheral nervous systems and are characterized by irreversible and progressive loss of previously intact neurological functions that increase with age And worsening, including Alzheimer's disease (Alzheimer diseases, ADs), Parkinson's disease (Parkinson's disease, PDs) and so on. Currently, the main treatment for ND is pharmacy, but the existing drugs can only relieve symptoms and have side effects such as diarrhea, nausea, headache, etc. In addition, according to the characteristics of ND, treatment is not limited to medical institutions, but more importantly, daily home care.

光学疗法(Light therapy,LT)是一种利用光线照射损伤部位从而缓解或治疗疾病的一种无创或微创治疗手段,无副作用。目前,光学疗法形成了包括强激光治疗、光动力治疗、弱激光治疗在内的三大光学治疗技术,已广泛应用于多种疾病的治疗。随着医学治疗模式的转变,弱激光治疗的疾病谱从常见病逐渐拓展到重大慢性增龄性疾病,治疗领域也从疾病治疗延伸到疾病预防,其应用的主战场也从医疗机构逐渐向社区和家庭倾斜。Light therapy (LT) is a non-invasive or minimally invasive treatment method that uses light to illuminate the damaged area to relieve or treat the disease without side effects. At present, optical therapy has formed three major optical therapy technologies including strong laser therapy, photodynamic therapy, and weak laser therapy, which have been widely used in the treatment of various diseases. With the transformation of the medical treatment mode, the disease spectrum of low-level laser treatment has gradually expanded from common diseases to major chronic ageing diseases, and the treatment field has also extended from disease treatment to disease prevention, and the main battlefield of its application has gradually shifted from medical institutions to communities. and family leaning.

目前,尚无针对ND治疗的弱激光治疗系统。At present, there is no low-level laser treatment system for ND treatment.

发明内容SUMMARY OF THE INVENTION

本发明提供一种智能化无损光疗系统,用以克服现有技术中存在的至少一个技术问题。The present invention provides an intelligent nondestructive phototherapy system to overcome at least one technical problem existing in the prior art.

本发明实施例提供一种智能化无损光疗系统,所述光疗系统包括:监控模块、处理模块和光疗模块,所述监控模型和所述处理模块连接,所述处理模块和所述光疗模块连接;所述监控模块获取患者的第一眼部信息和第二眼部信息,将所述第一眼部信息和所述第二眼部信息发送给所述处理模块,所述第一眼部信息和所述第二眼部信息包括瞳孔大小、眼球血丝分布情况,所述第一眼部信息和所述第二眼部信息的获取时间间隔预设时间段;所述处理模块根据获取到的所述第一眼部信息和所述第二眼部信息,生成所述患者眼部当前的变化参数;根据所述变化参数、当前的第一治疗参数和预设的调整幅度,生成第二治疗参数,以及将所述第二治疗参数发送给所述光疗模块;所述第一治疗参数和所述第二治疗参数包括光照功率和光照频率;所述光疗模块根据接收到的所述第二治疗参数调整治疗光源的光照剂量。An embodiment of the present invention provides an intelligent non-destructive phototherapy system, the phototherapy system includes: a monitoring module, a processing module and a phototherapy module, the monitoring model is connected to the processing module, and the processing module is connected to the phototherapy module; The monitoring module acquires the first eye information and the second eye information of the patient, and sends the first eye information and the second eye information to the processing module, and the first eye information and the second eye information are sent to the processing module. The second eye information includes pupil size and distribution of blood capillaries of the eyeball, and the acquisition time interval of the first eye information and the second eye information is a preset time period; the processing module is based on the acquired The first eye information and the second eye information are used to generate the current change parameter of the patient's eye; the second treatment parameter is generated according to the change parameter, the current first treatment parameter and the preset adjustment range, and sending the second treatment parameter to the phototherapy module; the first treatment parameter and the second treatment parameter include illumination power and illumination frequency; the phototherapy module adjusts according to the received second treatment parameter The light dose of the therapeutic light source.

可选的,所述第一眼部信息包括第一时刻眼部信息和第二时刻的眼部信息,所述第二眼部信息包括第三时刻眼部信息和第四时刻的眼部信息;所述处理模块根据获取到的所述第一眼部信息和所述第二眼部信息,生成所述患者眼部当前的变化参数的步骤,包括:所述处理模块根据所述第一时刻的眼部信息和第二时刻的眼部信息,生成患者的第一眼部信息;根据所述第三时刻的眼部信息和第四时刻的眼部信息,生成患者的第二眼部信息;其中,所述第一时刻和所述第二时刻、所述第三时刻和所述第四时刻均间隔预设的第一时段,所述第二时刻和所述第三时刻间隔预设的第二时段。Optionally, the first eye information includes eye information at a first moment and eye information at a second moment, and the second eye information includes eye information at a third moment and eye information at a fourth moment; The step of generating, by the processing module, the current change parameter of the patient's eye according to the acquired first eye information and the second eye information, includes: the processing module according to the first moment of The eye information and the eye information at the second moment are used to generate the first eye information of the patient; the second eye information of the patient is generated according to the eye information at the third moment and the eye information at the fourth moment; wherein , the first time and the second time, the third time and the fourth time are all separated by a preset first time period, and the second time and the third time are separated by a preset second time time period.

可选的,所述第一眼部信息和第二眼部信息还包括眨眼频率;所述变化参数包括:瞳孔变量、眼球血丝分布密度变量和眨眼频率变量;第二治疗参数包括第三治疗参数和第四治疗参数;所述根据所述变化参数、当前的第一治疗参数和预设的调整幅度,生成第二治疗参数的步骤,包括:所述处理模块根据患者的瞳孔变化量、眼球血丝分布密度变化量和眨眼频率变化量,计算当前的适应度值;所述处理模块根据所述适应度值和预设的适应度值分区表,判断当前的所述第一治疗参数是否与所述患者匹配;若匹配,则所述处理模块基于所述第一治疗参数,上调预设的调整幅度,生成第三治疗参数;若不匹配,则所述处理模块根据所述第一治疗参数和预设的调整幅度,下调治疗参数,生成第四治疗参数。Optionally, the first eye information and the second eye information also include blinking frequency; the variation parameters include: pupil variable, eyeball distribution density variable and blinking frequency variable; the second treatment parameter includes the third treatment parameter and the fourth treatment parameter; the step of generating the second treatment parameter according to the change parameter, the current first treatment parameter and the preset adjustment range includes: the processing module according to the patient's pupil change amount, eyeball capillaries Distribution density change and blink frequency change, and calculate the current fitness value; the processing module judges whether the current first treatment parameter is consistent with the fitness value according to the fitness value and the preset fitness value partition table. The patient is matched; if it matches, the processing module increases the preset adjustment range based on the first treatment parameter to generate a third treatment parameter; if it does not match, the processing module according to the first treatment parameter and the preset Set the adjustment range, lower the treatment parameter, and generate the fourth treatment parameter.

可选的,所述预设的适应度值分区表包括多个适应度值所在区间与评价的一一对应关系,所述评价包括适应、轻度不适应、不适应、严重不适应。Optionally, the preset fitness value partition table includes a one-to-one correspondence between the intervals in which the plurality of fitness values are located and the evaluation, and the evaluation includes adaptation, mild discomfort, unfitness, and severe unfitness.

可选的,所述所述处理模块根据所述第一治疗参数和预设的调整幅度,下调治疗参数,生成第四治疗参数的步骤,包括:若所述适应度值在所述预设的适应度值分区表中的评价为轻度不适应,则确定实际下调幅度为一倍的预设的调整幅度;若所述适应度值在所述预设的适应度值分区表中的评价为不适应,则确定实际下调幅度为两倍的预设的调整幅度;若所述适应度值在所述预设的适应度值分区表中的评价为严重不适应,则确定实际下调幅度为三倍的预设的调整幅度;在所述第一治疗参数的基础上,下调所述实际下调幅度,生成第四治疗参数。Optionally, the step of lowering the treatment parameter by the processing module to generate a fourth treatment parameter according to the first treatment parameter and a preset adjustment range includes: if the fitness value is within the preset adjustment range. If the evaluation in the fitness value partition table is slightly unsuitable, it is determined that the actual downward adjustment range is a preset adjustment range of one time; if the evaluation of the fitness value in the preset fitness value partition table is If it is not suitable, the actual adjustment range is determined to be twice the preset adjustment range; if the evaluation of the fitness value in the preset fitness value partition table is severely unsuitable, the actual adjustment range is determined to be three. times the preset adjustment range; on the basis of the first treatment parameter, the actual downward adjustment range is lowered to generate a fourth treatment parameter.

可选的,所述评价还包括过敏;在所述所述处理模块根据所述适应度值,在预设的适应度值分区表中找到对应的适应度值的评价的步骤之后,所述方法还包括:若评价为过敏,则所述处理模块向所述光疗模块发送停止治疗指令;所述光疗模块在接收到所述停止治疗指令后,关闭所述治疗光源。Optionally, the evaluation further includes allergies; after the processing module finds the evaluation of the corresponding fitness value in the preset fitness value partition table according to the fitness value, the method It also includes: if the evaluation is allergy, the processing module sends a treatment stop instruction to the phototherapy module; the phototherapy module turns off the treatment light source after receiving the treatment stop instruction.

可选的,所述系统还包括调整模块;所述调整模块获取第五治疗参数,将所述第五治疗参数发送给所述光疗模块;所述光疗模块根据接收到的所述第五治疗参数对光源的光照剂量进行调整。Optionally, the system further includes an adjustment module; the adjustment module acquires a fifth treatment parameter, and sends the fifth treatment parameter to the phototherapy module; the phototherapy module receives the fifth treatment parameter according to the Adjust the light dose of the light source.

可选的,所述智能化无损光疗系统包括智能化无损化光疗眼镜;所述治疗模块为所述智能化无损化光疗眼镜上的透明LED脉冲光镜片;所述监控模块为设置在所智能化无损化光疗眼镜镜框上的超清监控摄像头。Optionally, the intelligent non-destructive phototherapy system includes intelligent non-destructive phototherapy glasses; the treatment module is a transparent LED pulsed light lens on the intelligent non-destructive phototherapy glasses; the monitoring module is set in the intelligent non-destructive phototherapy glasses. Ultra-clear surveillance camera on the frame of non-destructive phototherapy glasses.

可选的,所述处理模块为设置在所述智能化无损化光疗眼镜上的微型处理器;所述调整模块设置在所述智能化无损化光疗眼镜侧面的镜腿部位,所述调整模块包括用于提高光照剂量的增量按键和用于降低光照剂量的减量按键;所述微型处理器分别与所述LED脉冲光镜片、超清监控摄像头和所述调整模块有线或无线连接。Optionally, the processing module is a microprocessor arranged on the intelligent nondestructive phototherapy glasses; the adjustment module is arranged on the temple part of the side of the intelligent nondestructive phototherapy glasses, and the adjustment module It includes an increment button for increasing the light dose and a decrement button for reducing the light dose; the microprocessor is respectively wired or wirelessly connected with the LED pulsed light lens, the ultra-clear surveillance camera and the adjustment module.

可选的,所述智能化无损光疗系统还包括远程操作终端;所述智能化无损化光疗眼镜还包括第一通信模块;所述远程操作终端中设置有所述处理模块、所述调整模块和第二通信模块;所述智能化无损化光疗眼镜和所述远程操作终端分别通过所述第一通信模块和所述第二通信模块连接。Optionally, the intelligent nondestructive phototherapy system further includes a remote operation terminal; the intelligent nondestructive phototherapy glasses further include a first communication module; the remote operation terminal is provided with the processing module, the adjustment module and the a second communication module; the intelligent nondestructive phototherapy glasses and the remote operation terminal are respectively connected through the first communication module and the second communication module.

本发明实施例的创新点包括:The innovative points of the embodiments of the present invention include:

1、本发明提出的智能化无损光疗系统,可以使用弱激光对神经退行性疾病(NDs)的患者进行治疗,相对药物治疗,本发明的光疗系统治疗对患者身体无任何副作用。是本发明实施例的创新点之一。1. The intelligent non-destructive phototherapy system proposed by the present invention can use weak laser light to treat patients with neurodegenerative diseases (NDs). Compared with drug therapy, the phototherapy system of the present invention does not have any side effects on the patient's body. This is one of the innovative points of the embodiments of the present invention.

2、本发明提出的智能化无损光疗系统中,处理模块可以根据监控模块实时监控患者的眼部情况,并根据患者当前的眼部情况自动调节光疗模块的光照剂量,使用方便且安全可靠,无需具备专业技能,便于患者居家使用。是本发明实施例的创新点之一。2. In the intelligent non-destructive phototherapy system proposed by the present invention, the processing module can monitor the patient's eye condition in real time according to the monitoring module, and automatically adjust the light dose of the phototherapy module according to the patient's current eye condition. With professional skills, it is convenient for patients to use at home. This is one of the innovative points of the embodiments of the present invention.

3、本发明提出的智能化无损光疗系统中,处理模块可以根据患者当前时间段的眼部信息,自动对光疗模块的光照剂量进行分阶段调整,避免出现由于光照剂量较大造成的患者眼部不适,以及光照剂量不足导致的治疗效果不佳等问题,兼顾患者体验感和治疗效果,以实现在患者眼部较为舒适的前提下,最大程度的提升治疗效果。是本发明实施例的创新点之一。3. In the intelligent non-destructive phototherapy system proposed by the present invention, the processing module can automatically adjust the illumination dose of the phototherapy module in stages according to the eye information of the patient in the current time period, so as to avoid the occurrence of eye damage caused by the large illumination dose. Discomfort, and poor treatment effect caused by insufficient light dose, take into account the patient's experience and treatment effect, so as to maximize the treatment effect under the premise that the patient's eyes are more comfortable. This is one of the innovative points of the embodiments of the present invention.

4、本发明提出的智能化无损光疗系统,小巧便捷,可随身携带,适于家庭的日常护理治疗,具体的,可以佩戴在患者头部,由于LED脉冲光镜片为透明,患者在治疗过程中视线不受影响,可以自由行动,使用起来非常方便,有较佳的使用体验。是本发明实施例的创新点之一。4. The intelligent non-destructive phototherapy system proposed by the present invention is small and convenient, can be carried around, and is suitable for daily nursing and treatment at home. Specifically, it can be worn on the patient's head. Since the LED pulsed light lens is transparent, the patient is in the treatment process. The line of sight is not affected, you can move freely, it is very convenient to use, and you have a better experience. This is one of the innovative points of the embodiments of the present invention.

附图说明Description of drawings

为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to explain the embodiments of the present invention or the technical solutions in the prior art more clearly, the following briefly introduces the accompanying drawings that need to be used in the description of the embodiments or the prior art. Obviously, the accompanying drawings in the following description are only These are some embodiments of the present invention. For those of ordinary skill in the art, other drawings can also be obtained according to these drawings without creative efforts.

图1为本发明提出的一种智能化无损光疗系统;Fig. 1 is a kind of intelligent non-destructive phototherapy system proposed by the present invention;

图2为本发明提出的另一种智能化无损光疗系统;Fig. 2 is another kind of intelligent non-destructive phototherapy system proposed by the present invention;

图3为本发明中步骤213的具体处理流程图;Fig. 3 is the specific processing flow chart of step 213 in the present invention;

图4为本发明提出的智能化无损化光疗眼镜;Fig. 4 is the intelligent non-destructive phototherapy glasses proposed by the present invention;

图5为本发明提出的智能化无损化光疗眼镜和远程操作终端。FIG. 5 is the intelligent nondestructive phototherapy glasses and remote operation terminal proposed by the present invention.

具体实施方式Detailed ways

下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有付出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only a part of the embodiments of the present invention, but not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative efforts shall fall within the protection scope of the present invention.

需要说明的是,本发明实施例及附图中的术语“包括”和“具有”以及它们任何变形,意图在于覆盖不排他的包含。例如包含了一系列步骤或单元的过程、方法、系统、产品或设备没有限定于已列出的步骤或单元,而是可选地还包括没有列出的步骤或单元,或可选地还包括对于这些过程、方法、产品或设备固有的其它步骤或单元。It should be noted that the terms "comprising" and "having" and any modifications thereof in the embodiments of the present invention and the accompanying drawings are intended to cover non-exclusive inclusion. For example, a process, method, system, product or device comprising a series of steps or units is not limited to the listed steps or units, but optionally also includes unlisted steps or units, or optionally also includes For other steps or units inherent to these processes, methods, products or devices.

本发明提出了一种智能化无损光疗系统,参考图1,图1为本发明提出的一种智能化无损光疗系统。如图1所示,智能化无损光疗系统包括:监控模块、处理模块和光疗模块,所述监控模块和所述处理模块连接,所述处理模块和所述光疗模块连接。光疗系统中各模块的交互流程如下:The present invention proposes an intelligent non-destructive phototherapy system. Referring to FIG. 1 , FIG. 1 is an intelligent non-destructive phototherapy system proposed by the present invention. As shown in FIG. 1 , the intelligent nondestructive phototherapy system includes: a monitoring module, a processing module and a phototherapy module, the monitoring module is connected to the processing module, and the processing module is connected to the phototherapy module. The interaction process of each module in the phototherapy system is as follows:

步骤101,所述监控模块获取患者的第一眼部信息和第二眼部信息,将所述第一眼部信息和所述第二眼部信息发送给所述处理模块。Step 101, the monitoring module acquires the first eye information and the second eye information of the patient, and sends the first eye information and the second eye information to the processing module.

其中,所述第一眼部信息和所述第二眼部信息包括瞳孔大小、眼球血丝分布情况,所述第一眼部信息和所述第二眼部信息的获取时间间隔预设时间段。Wherein, the first eye information and the second eye information include pupil size and distribution of eye blood caps, and the acquisition time interval of the first eye information and the second eye information is a preset time period.

在本步骤中,监控模块可以获取患者的第一眼部信息和第二眼部信息,其中,第一眼部信息的获取时间与第二眼部时间的获取时间可以间隔预设时间段,预设时间段可以为10-100μs,第一眼部信息和第二眼部信息可以反应附近这段时间内患者眼部的变化情况,为后续步骤判断光疗模块的治疗参数是否合适提供参考。In this step, the monitoring module may acquire the first eye information and the second eye information of the patient, wherein the acquisition time of the first eye information and the acquisition time of the second eye time may be separated by a preset time period, The time period can be 10-100 μs, and the first eye information and the second eye information can reflect the changes of the patient's eyes during the nearby period, and provide a reference for the subsequent steps to determine whether the treatment parameters of the phototherapy module are appropriate.

需要说明的是,光疗模块是通过照射患者眼部达到治疗效果的,为了实时监测患者的眼部情况,第一眼部信息和第二眼部信息可以包括患者的瞳孔大小、眼球血丝分布情况等能够反应患者对光疗模块治疗的适应程度的患者的临床数据。It should be noted that the phototherapy module achieves the therapeutic effect by irradiating the patient's eyes. In order to monitor the patient's eye condition in real time, the first eye information and the second eye information may include the patient's pupil size, the distribution of eyeballs, etc. The clinical data of the patient can reflect the degree of adaptation of the patient to the treatment of the phototherapy module.

可以理解的,当光疗模块的治疗参数不合适时,可能造成患者的瞳孔变化幅度较大,眼球血丝增多等不良反应。It is understandable that when the treatment parameters of the phototherapy module are inappropriate, adverse reactions such as a large change in the pupil of the patient and an increase in bloodshot in the eyeball may be caused.

步骤103,所述处理模块根据接收到的所述第一眼部信息和所述第二眼部信息,生成所述患者眼部当前的变化参数。Step 103, the processing module generates the current change parameter of the patient's eye according to the received first eye information and the second eye information.

在本步骤中,处理模块可以根据监控模块发送的第一眼部信息和第二眼部信息,生成反应患者当前对光疗模块治疗效果反应程度的变化参数,达到实时监控患者眼部情况的目的。In this step, the processing module may generate a change parameter reflecting the patient's current response to the treatment effect of the phototherapy module according to the first eye information and the second eye information sent by the monitoring module, so as to monitor the patient's eye condition in real time.

需要说明的是,变化参数可以体现第一眼部信息和第二眼部信息的获取时间段内,也即当前时间内的眼部变化情况。如果变化参数较大,说明患者眼部不适应当前的治疗光源,也可能已出现过敏反应,可以通过修改治疗参数降低光照剂量,或者停止光疗。It should be noted that the change parameter may reflect the change of the eye during the acquisition time period of the first eye information and the second eye information, that is, the current time. If the change parameter is large, it means that the patient's eyes are not adapted to the current treatment light source, and allergic reactions may also occur. The light dose can be reduced by modifying the treatment parameters, or the phototherapy can be stopped.

步骤105,所述处理模块根据所述变化参数、当前的第一治疗参数和预设的调整幅度,生成第二治疗参数,以及将所述第二治疗参数发送给所述光疗模块。Step 105, the processing module generates a second treatment parameter according to the change parameter, the current first treatment parameter and the preset adjustment range, and sends the second treatment parameter to the phototherapy module.

其中,所述第一治疗参数和所述第二治疗参数包括光照功率和光照频率。Wherein, the first treatment parameter and the second treatment parameter include illumination power and illumination frequency.

在本步骤中,处理模块可以根据生成的变化参数,确定当前的第一治疗参数对患者是否合适,若合适,则可以按照预设的调整幅度,在当前的第一治疗参数的基础上,上调各项治疗参数,若不合适,则可以根据预设的调整幅度,在第一治疗参数的基础上,下调各项治疗参数,最终得到与患者当前状态匹配的第二治疗参数,并且将第二治疗参数发送给光疗模块,以便光疗模块及时调整治疗参数,调整光照剂量。一方面,在患者的身体可以接受的前提下,提高光照剂量,增进治疗效果,另一方面,若患者出现不适反应,则可以及时降低光照剂量甚至停止光疗,以提高患者的使用体验。In this step, the processing module can determine whether the current first treatment parameter is suitable for the patient according to the generated change parameter, and if it is suitable, it can be adjusted upward based on the current first treatment parameter according to the preset adjustment range. If each treatment parameter is not suitable, you can adjust each treatment parameter according to the preset adjustment range on the basis of the first treatment parameter, and finally obtain the second treatment parameter matching the current state of the patient, and adjust the second treatment parameter. The treatment parameters are sent to the phototherapy module, so that the phototherapy module can adjust the treatment parameters and the light dose in time. On the one hand, under the premise that the patient's body can accept it, the light dose can be increased to improve the therapeutic effect. On the other hand, if the patient has an uncomfortable reaction, the light dose can be reduced or even stopped in time to improve the patient's experience.

需要说明的是,光疗模块可以为LED脉冲光模块,治疗参数可以包括光照功率、光照频率等能够影响光疗模块的光照剂量的参数。It should be noted that the phototherapy module may be an LED pulsed light module, and the treatment parameters may include parameters such as illumination power and illumination frequency that can affect the illumination dose of the phototherapy module.

步骤107,所述疗模块根据接收到的所述第二治疗参数调整治疗光源的光照剂量。Step 107, the treatment module adjusts the light dose of the treatment light source according to the received second treatment parameter.

在本步骤中,光疗模块可以根据处理模块发送的新生成的第二治疗参数,调整治疗光源的光照功率和光照频率等治疗参数,以使治疗光源的光照剂量与患者的眼部情况相适应,避免出现眼部过敏或眼部不适,提升患者的使用体验。In this step, the phototherapy module can adjust the treatment parameters such as the illumination power and illumination frequency of the treatment light source according to the newly generated second treatment parameter sent by the processing module, so that the illumination dose of the treatment light source is adapted to the eye condition of the patient, Avoid eye allergies or eye discomfort, and improve patient experience.

可见,本发明提出的智能化无损光疗系统,相对药物治疗,本发明的光疗系统治疗对患者身体无任何副作用;此外,处理模块可以通过监控模块实时监测患者的眼部情况并根据患者当前的眼部情况自动调节光疗模块的光照剂量,使用方便且安全可靠,无需具备专业技能,便于患者居家使用,并且可以提升患者的使用体验。It can be seen that the intelligent non-destructive phototherapy system proposed by the present invention has no side effects on the patient's body compared with drug therapy; in addition, the processing module can monitor the patient's eye condition in real time through the monitoring module It can automatically adjust the light dose of the phototherapy module according to the external conditions, which is convenient, safe and reliable to use, without professional skills, which is convenient for patients to use at home, and can improve the use experience of patients.

本发明还提出另一种智能化无损光疗系统,参考图2,图2为本发明提出的另一种智能化无损光疗系统。如图2所示,另一种智能化无损光疗系统的处理步骤如下:The present invention also proposes another intelligent non-destructive phototherapy system. Referring to FIG. 2 , FIG. 2 is another intelligent non-destructive phototherapy system proposed by the present invention. As shown in Figure 2, the processing steps of another intelligent non-destructive phototherapy system are as follows:

步骤201,所述监控模块获取患者的第一时刻的眼部信息、第二时刻的眼部信息、第三时刻的眼部信息和第四时刻的眼部信息。Step 201, the monitoring module acquires the eye information of the patient at the first moment, the eye information at the second moment, the eye information at the third moment, and the eye information at the fourth moment.

其中,所述第一时刻和所述第二时刻、所述第三时刻和所述第四时刻均间隔预设的第一时段,所述第二时刻和所述第三时刻间隔预设的第二时段。Wherein, the first time and the second time, the third time and the fourth time are all separated by a preset first time period, and the second time and the third time are separated by a preset first time period. Second period.

需要说明的是,第一时刻和第二时刻,第三时刻和第四时刻均间隔预设的第一时段,预设的第一时段可以是根据实际情况设置,通常情况下可以设置为10μs。第二时刻和第三时刻的间隔为预设的第二时段,通常情况下可以设置为100μs。It should be noted that the first time, the second time, the third time and the fourth time are all separated by a preset first time period. The preset first time period can be set according to the actual situation, and can be set to 10 μs under normal circumstances. The interval between the second moment and the third moment is a preset second time period, which can be set to 100 μs under normal circumstances.

步骤203,所述处理模块根据所述第一时刻的眼部信息和第二时刻的眼部信息,生成患者的第一眼部信息;根据所述第三时刻的眼部信息和第四时刻的眼部信息,生成患者的第二眼部信息。Step 203, the processing module generates the first eye information of the patient according to the eye information at the first moment and the eye information at the second moment; according to the eye information at the third moment and the eye information at the fourth moment; Eye information, generating the second eye information of the patient.

在本步骤中,处理模块可以根据监控模块发送的第一时刻的眼部信息和第二时刻的眼部信息,生成患者的第一眼部信息,第一眼部信息可以是第一时刻的眼部信息和第二时刻的眼部信息的均值,也可以是基于第一时刻的眼部信息和第二时刻的眼部信息,经数据处理后得到的数值。同理,第二眼部信息也是基于第三时刻的眼部信息和第四时刻的眼部信息得到的。In this step, the processing module may generate the first eye information of the patient according to the eye information at the first moment and the eye information at the second moment sent by the monitoring module, and the first eye information may be the eye at the first moment. The average value of the eye information at the second moment and the eye information at the second moment may also be a value obtained after data processing based on the eye information at the first moment and the eye information at the second moment. Similarly, the second eye information is also obtained based on the eye information at the third moment and the eye information at the fourth moment.

步骤205,所述处理模块根据获取到的所述第一眼部信息和所述第二眼部信息,生成所述患者眼部当前的变化参数。Step 205, the processing module generates the current change parameter of the patient's eye according to the acquired first eye information and the second eye information.

需要说明的是,所述第一眼部信息和第二眼部信息还包括眨眼频率;对应的,所述变化参数可以包括:瞳孔变量、眼球血丝分布密度变量和眨眼频率变量等能够反应眼部适应程度的参数。It should be noted that the first eye information and the second eye information also include blinking frequency; correspondingly, the variation parameters may include: pupil variable, eyeball distribution density variable, blinking frequency variable, etc. The fitness parameter.

步骤207,所述处理模块根据患者的瞳孔变化量、眼球血丝分布密度变化量和眨眼频率变化量,计算当前的适应度值。Step 207, the processing module calculates the current fitness value according to the change of the pupil of the patient, the change of the distribution density of the eyeball capillaries, and the change of the blinking frequency.

在本步骤中,处理模块可以根据患者的瞳孔变化量、眼球血丝分布密度变化量和眨眼频率变化量,计算患者当前的适应度值。In this step, the processing module may calculate the patient's current fitness value according to the patient's pupil change amount, the eye blood capillary distribution density change amount and the eye blink frequency change amount.

具体的,计算适应度值的的公式如下所示:Specifically, the formula for calculating the fitness value is as follows:

x=50%·a+20%·b+30%·c (1)x=50%·a+20%·b+30%·c (1)

在公式(1)中,a为瞳孔变量,b为眼球血丝分布密度变量,c为眨眼频率变化量。In formula (1), a is the pupil variable, b is the eyeball blood capillary distribution density variable, and c is the blink frequency variation.

需要说明的是,各变化量对应的权重值,比如在公式(1)中瞳孔变量对应的50%权重值,眼球血丝分布密度变量对应的20%权重值,眨眼频率变化量对应的30%权重值,均可以根据实际情况来调整。It should be noted that the weight value corresponding to each change amount, such as the 50% weight value corresponding to the pupil variable in formula (1), the 20% weight value corresponding to the eye blood capillary distribution density variable, and the 30% weight corresponding to the change in blink frequency. The value can be adjusted according to the actual situation.

步骤209,所述处理模块根据所述适应度值和预设的适应度值分区表,判断当前的所述第一治疗参数是否与所述患者匹配;若匹配,则执行步骤211,若不匹配,则执行步骤213。Step 209, the processing module judges whether the current first treatment parameter matches the patient according to the fitness value and the preset fitness value partition table; if it matches, executes step 211, if it does not match , step 213 is executed.

在本步骤中,处理模块可以根据计算出的适应度值,在预设的适应度值分区表中进行查询,根据查询结果判断光疗模块当前使用的第一治疗参数,是否与患者的眼部状态相匹配。若匹配,则执行步骤207,以便及时增大光疗模块的光照剂量,提高治疗效果,若不匹配,则执行步骤209,以及时降低光照剂量,避免对患者身体造成损伤。In this step, the processing module may query the preset fitness value partition table according to the calculated fitness value, and determine whether the first treatment parameter currently used by the phototherapy module is consistent with the patient's eye state according to the query result. match. If it matches, go to step 207 to increase the light dose of the phototherapy module in time to improve the treatment effect; if not, go to step 209 to reduce the light dose in time to avoid damage to the patient's body.

在本步骤中,处理模块可以根据计算出的适应度值,在预设的适应度值分区表中找到与适应度值对应的评价,以进一步确定与患者身体相匹配的处理方式。In this step, the processing module may find the evaluation corresponding to the fitness value in the preset fitness value partition table according to the calculated fitness value, so as to further determine the processing method that matches the patient's body.

可选的,所述预设的适应度值分区表可以包括多个适应度值所在区间与评价的一一对应关系,所述评价可以包括适应、轻度不适应、不适应、严重不适应和过敏。具体的,预设的适应度值分区表可以如表1所示。Optionally, the preset fitness value partition table may include a one-to-one correspondence between the intervals where the plurality of fitness values are located and the evaluation, and the evaluation may include adaptation, mild discomfort, unfitness, severe unfitness and allergy. Specifically, the preset fitness value partition table may be as shown in Table 1.

适应度值(请填写)Fitness value (please fill in) 评价Evaluation ≥90≥90 适应adapt 80-9080-90 轻度不适应mild discomfort 70-8070-80 不适应not fit 60-7060-70 严重不适应severe discomfort ≤60≤60 过敏allergy

表1Table 1

当然,在实际应用中,可以根据患者的身体情况,设置预设的适应度值分区表。Of course, in practical applications, a preset fitness value partition table may be set according to the patient's physical condition.

步骤211,所述处理模块基于所述第一治疗参数,上调预设的调整幅度,生成第三治疗参数,以及将所述第三治疗参数发送给所述光疗模块。Step 211, the processing module increases a preset adjustment range based on the first treatment parameter, generates a third treatment parameter, and sends the third treatment parameter to the phototherapy module.

在本步骤中,由于光疗模块当前使用的第一治疗参数,与患者的眼部状态相匹配,因此,可以基于所述第一治疗参数,上调预设的调整幅度,生成第三治疗参数,以及将所述第三治疗参数发送给所述光疗模块,这样可以在患者的眼部舒适的前提下,及时增大光疗模块的光照剂量,提高治疗效果。In this step, since the first treatment parameter currently used by the phototherapy module matches the eye state of the patient, the preset adjustment range may be increased based on the first treatment parameter to generate a third treatment parameter, and The third treatment parameter is sent to the phototherapy module, so that the light dose of the phototherapy module can be increased in time on the premise that the patient's eyes are comfortable, and the treatment effect can be improved.

通常情况下,预设的调整幅度可以为10-40HZ。Under normal circumstances, the preset adjustment range can be 10-40HZ.

需要说明的是,为了与前一个实施例对应,前一个实施例中出现的第二治疗参数可以包括本实施例中的第三治疗参数和第四治疗参数。It should be noted that, in order to correspond to the previous embodiment, the second treatment parameter in the previous embodiment may include the third treatment parameter and the fourth treatment parameter in this embodiment.

步骤213,所述处理模块根据所述第一治疗参数和预设的调整幅度,下调治疗参数,生成第四治疗参数,以及将所述第四治疗参数发送给所述光疗模块。Step 213, the processing module down-regulates the treatment parameter according to the first treatment parameter and a preset adjustment range, generates a fourth treatment parameter, and sends the fourth treatment parameter to the phototherapy module.

在本步骤中,由于光疗模块当前使用的第一治疗参数,与患者的眼部状态不匹配,因此,可以基于所述第一治疗参数,下调预设的调整幅度,生成第四治疗参数,以及将所述第四治疗参数发送给所述光疗模块,以改善患者眼部的不良状态,避免对患者身体造成损伤,提升患者体验。In this step, since the first treatment parameter currently used by the phototherapy module does not match the eye state of the patient, the preset adjustment range may be adjusted down based on the first treatment parameter to generate a fourth treatment parameter, and The fourth treatment parameter is sent to the phototherapy module, so as to improve the poor condition of the patient's eyes, avoid damage to the patient's body, and improve the patient's experience.

可选的,参考图3,图3为本发明中步骤209的具体处理流程图,如图3所示,步骤213具体可以包括:Optionally, referring to FIG. 3, FIG. 3 is a specific processing flowchart of step 209 in the present invention. As shown in FIG. 3, step 213 may specifically include:

子步骤31,若所述适应度值在所述预设的适应度值分区表中的评价为轻度不适应,则确定实际下调幅度为一倍的预设的调整幅度;若所述适应度值在所述预设的适应度值分区表中的评价为不适应,则确定实际下调幅度为两倍的预设的调整幅度;若所述适应度值在所述预设的适应度值分区表中的评价为严重不适应,则确定实际下调幅度为三倍的预设的调整幅度。Sub-step 31, if the evaluation of the fitness value in the preset fitness value partition table is slightly unsuitable, determine that the actual adjustment range is one time the preset adjustment range; If the value in the preset fitness value partition table is evaluated as unsuitable, then determine that the actual adjustment range is twice the preset adjustment range; if the fitness value is in the preset fitness value partition If the evaluation in the table is serious incompatibility, the actual adjustment range is determined to be three times the preset adjustment range.

子步骤32,在所述第一治疗参数的基础上,下调所述实际下调幅度,生成第四治疗参数。Sub-step 32, on the basis of the first treatment parameter, down-regulates the actual down-regulation range to generate a fourth treatment parameter.

具体的,在当前的光疗模块的光照剂量与患者不匹配的情况下,更加细化下调光照剂量的实现方式,分阶段下调光照剂量,评价较轻的,光照剂量的下调幅度较小,评价较严重的,光照剂量的下调幅度较大。在对患者身体不造成损伤的情况下,尽量保证光疗模块的治疗效果。Specifically, in the case that the light dose of the current phototherapy module does not match the patient, the implementation method of reducing the light dose is more refined, and the light dose is reduced in stages. Seriously, the down-regulation of the light dose is larger. In the case of not causing damage to the patient's body, try to ensure the therapeutic effect of the phototherapy module.

可选的,所述评价还可以包括过敏;Optionally, the evaluation may also include allergies;

若评价为过敏,则所述处理模块向所述光疗模块发送停止治疗指令;If the evaluation is allergy, the processing module sends a stop treatment instruction to the phototherapy module;

所述光疗模块在接收到所述停止治疗指令后,关闭所述治疗光源。The light therapy module turns off the therapy light source after receiving the stop therapy instruction.

具体的,当适应度值在预设的适应度值分区表中对应的评价为过敏时,说明患者的眼部已经出现过敏状态,处理模块立刻向所述光疗模块发送停止治疗指令,光疗模块在接收到所述停止治疗指令后,关闭所述治疗光源,以避免加重患者眼部的过敏情况。Specifically, when the corresponding evaluation of the fitness value in the preset fitness value partition table is allergy, it means that the patient's eye has an allergic state, and the processing module immediately sends a stop treatment instruction to the phototherapy module, and the phototherapy module is in the After receiving the instruction to stop the treatment, the treatment light source is turned off to avoid aggravating the allergic condition of the patient's eyes.

具体的,瞳孔变量的预设区间可以为2.5-4mm,当瞳孔变量超过该预设区间时,处理模块向光疗模块发送停止治疗指令;眼球血丝分布密度变量的预设区间可以为-5%-5%,当眼球血丝分布密度变量超出该预设区间时,处理模块向光疗模块发送停止治疗指令;眨眼频率变化量的预设区间可以为10-30次/分钟,当眨眼频率变化量该预设区域间时,处理模块向光疗模块发送停止治疗指令。Specifically, the preset interval of the pupil variable can be 2.5-4mm. When the pupil variable exceeds the preset interval, the processing module sends a stop treatment instruction to the phototherapy module; the preset interval of the eye blood capillary distribution density variable can be -5%- 5%, when the variable of eyeball distribution density exceeds the preset interval, the processing module sends a stop treatment instruction to the phototherapy module; the preset interval of the blink frequency change can be 10-30 times/min, when the blink frequency change is the preset interval. When the zone interval is set, the processing module sends a stop treatment instruction to the phototherapy module.

在具体实施中,所述系统还包括调整模块;In a specific implementation, the system further includes an adjustment module;

所述调整模块获取第五治疗参数,将所述第五治疗参数发送给所述光疗模块;The adjustment module acquires a fifth treatment parameter, and sends the fifth treatment parameter to the phototherapy module;

所述光疗模块根据接收到的所述第五治疗参数对光源的光照剂量进行调整。The light therapy module adjusts the light dose of the light source according to the received fifth treatment parameter.

具体的,在部分场地下,可以通过调整模块手动输入治疗参数,记为第五治疗参数,由调整模块将第五治疗参数发送给光疗模块,以便光疗模块将光源的光照剂量按照第五治疗参数进行调整。Specifically, in some venues, the treatment parameters can be manually input through the adjustment module, which is recorded as the fifth treatment parameter, and the adjustment module sends the fifth treatment parameter to the phototherapy module, so that the phototherapy module can adjust the light dose of the light source according to the fifth treatment parameter. make adjustments.

可见,本发明提出的另一种智能化无损光疗系统,处理模块可以根据患者当前时间段的眼部信息,自动对光疗模块的光照剂量进行分阶段调整,避免出现由于光照剂量较大造成的患者眼部不适,以及光照剂量不足导致的治疗效果不佳等问题,兼顾患者体验感和治疗效果,以实现在患者眼部较为舒适的前提下,最大程度的提升治疗效果。It can be seen that, in another intelligent non-destructive phototherapy system proposed by the present invention, the processing module can automatically adjust the illumination dose of the phototherapy module in stages according to the eye information of the patient in the current time period, so as to avoid the occurrence of patients caused by large illumination dose. Eye discomfort and poor treatment effect caused by insufficient light dose, taking into account the patient's experience and treatment effect, so as to maximize the treatment effect under the premise that the patient's eyes are more comfortable.

在具体实施中,本发明提出的智能化无损光疗系统具体可以是一种智能化无损光疗眼镜。参考图4,图4为本发明提出的智能化无损化光疗眼镜。In a specific implementation, the intelligent lossless phototherapy system proposed by the present invention may specifically be a kind of intelligent lossless phototherapy glasses. Referring to FIG. 4 , FIG. 4 is the intelligent nondestructive phototherapy glasses proposed by the present invention.

如图4所示,所述治疗模块为所述智能化无损化光疗眼镜40上的透明LED脉冲光镜片401;所述监控模块为设置在所智能化无损化光疗眼镜40镜框上的超清监控摄像头402;所述处理模块为设置在所述光疗眼镜40上的微型处理器403;所述调整模块设置在所述光疗眼镜40侧面的镜腿部位,所述调整模块包括用于提高光照剂量的按键404,具体包括增量按键和减量按键。As shown in FIG. 4 , the treatment module is a transparent LED pulsed light lens 401 on the intelligent non-destructive phototherapy glasses 40 ; the monitoring module is an ultra-clear monitor set on the frame of the intelligent non-destructive phototherapy glasses 40 camera 402; the processing module is a microprocessor 403 arranged on the phototherapy glasses 40; the adjustment module is arranged at the temple part of the side of the phototherapy glasses 40, and the adjustment module includes a device for increasing the light dose The key 404 includes an increment key and a decrement key.

所述微型处理器403分别与所述LED脉冲光镜片401、超清监控摄像头402和所述调整模块404有线或无线连接。The microprocessor 403 is respectively connected with the LED pulsed light lens 401 , the ultra-clear surveillance camera 402 and the adjustment module 404 by wire or wirelessly.

具体的,智能化无损化光疗眼镜40内部模块的交互流程如下:Specifically, the interaction process of the internal modules of the intelligent nondestructive phototherapy glasses 40 is as follows:

智能化无损化光疗眼镜40中的所述超清监控摄像头402获取患者的第一眼部信息和第二眼部信息,将所述第一眼部信息和所述第二眼部信息通过第一通信模块405发送给微型处理器403,所述第一眼部信息和所述第二眼部信息包括瞳孔大小、眼球血丝分布情况,所述第一眼部信息和所述第二眼部信息的获取时间间隔预设时间段;The ultra-clear monitoring camera 402 in the intelligent nondestructive phototherapy glasses 40 obtains the first eye information and the second eye information of the patient, and passes the first eye information and the second eye information through the first eye information and the second eye information. The communication module 405 sends to the microprocessor 403, the first eye information and the second eye information include the pupil size, the distribution of eyeball blood, and the difference between the first eye information and the second eye information. Get the time interval preset time period;

微型处理器403根据获取到的所述第一眼部信息和所述第二眼部信息,生成所述患者眼部当前的变化参数;根据所述变化参数、当前的第一治疗参数和预设的调整幅度,生成第二治疗参数,以及将所述第二治疗参数通过第二通信模块发送给透明LED脉冲光镜片401;所述第一治疗参数和所述第二治疗参数包括光照功率和光照频率;The microprocessor 403 generates the current change parameter of the patient's eye according to the acquired first eye information and the second eye information; according to the change parameter, the current first treatment parameter and the preset The adjustment range of the second treatment parameter is generated, and the second treatment parameter is sent to the transparent LED pulsed light lens 401 through the second communication module; the first treatment parameter and the second treatment parameter include illumination power and illumination frequency;

透明LED脉冲光镜片401根据接收到的所述第二治疗参数调整治疗光源的光照剂量。The transparent LED pulsed light lens 401 adjusts the light dose of the treatment light source according to the received second treatment parameter.

处理方法中的具体细节可以参考前文实施例,在此不再赘述。For the specific details of the processing method, reference may be made to the foregoing embodiments, which will not be repeated here.

在本实施例中,智能化无损化光疗眼镜能够解决目前治疗仪治疗时无法实时监控治疗过程的问题,可以实时监控患者眼部情况,以自适应调节光治疗剂量。此外,智能化无损化光疗眼镜具有操作自由性,在不影响治疗效果的前提下,患者在接收治疗的同时可以做其他事情,使用方便安全,适用于居家的日常护理。In this embodiment, the intelligent nondestructive phototherapy glasses can solve the problem that the current therapeutic apparatus cannot monitor the treatment process in real time, and can monitor the patient's eye condition in real time to adjust the phototherapy dose adaptively. In addition, the intelligent non-destructive phototherapy glasses have the freedom of operation. Under the premise of not affecting the treatment effect, the patient can do other things while receiving treatment. It is convenient and safe to use and suitable for daily care at home.

在具体实施中,本发明再提出一种光疗智能装置,具体包括智能化无损化光疗眼镜和远程操作终端。参考图5,图5为本发明提出的智能化无损化光疗眼镜和远程操作终端。In a specific implementation, the present invention further proposes an intelligent device for phototherapy, which specifically includes intelligent nondestructive phototherapy glasses and a remote operation terminal. Referring to FIG. 5 , FIG. 5 is an intelligent nondestructive phototherapy glasses and a remote operation terminal proposed by the present invention.

如图5所示,所述光疗智能眼睛40中设置有透明LED脉冲光镜片401、超清监控摄像头402和第一通信模块405。所述远程操作终端50中设置有处理模块501、调整模块502和第二通信模块503。所述第一通信模块405分别与所述超清监控摄像头402、所述透明LED脉冲光镜片401连接。所述远程操作终端50中的第二通讯模块503与所述智能化无损化光疗眼镜40中的第二通讯模块405无线连接。As shown in FIG. 5 , the phototherapy smart eye 40 is provided with a transparent LED pulsed light lens 401 , an ultra-clear monitoring camera 402 and a first communication module 405 . The remote operation terminal 50 is provided with a processing module 501 , an adjustment module 502 and a second communication module 503 . The first communication module 405 is respectively connected with the ultra-clear monitoring camera 402 and the transparent LED pulsed light lens 401 . The second communication module 503 in the remote operation terminal 50 is wirelessly connected with the second communication module 405 in the intelligent lossless chemo-phototherapy glasses 40 .

具体的,智能化无损化光疗眼镜40和远程操作终端50的交互流程如下:Specifically, the interaction process between the intelligent nondestructive phototherapy glasses 40 and the remote operation terminal 50 is as follows:

智能化无损化光疗眼镜40中的所述超清监控摄像头402获取患者的第一眼部信息和第二眼部信息,将所述第一眼部信息和所述第二眼部信息通过第一通信模块405发送给远程操作终端50中的处理模块501,所述第一眼部信息和所述第二眼部信息包括瞳孔大小、眼球血丝分布情况,所述第一眼部信息和所述第二眼部信息的获取时间间隔预设时间段;The ultra-clear monitoring camera 402 in the intelligent nondestructive phototherapy glasses 40 obtains the first eye information and the second eye information of the patient, and passes the first eye information and the second eye information through the first eye information and the second eye information. The communication module 405 sends to the processing module 501 in the remote operation terminal 50, the first eye information and the second eye information include pupil size, the distribution of eyeball blood, the first eye information and the second eye information. The acquisition time interval of the second eye information is a preset time period;

远程操作终端50中的处理模块501根据获取到的所述第一眼部信息和所述第二眼部信息,生成所述患者眼部当前的变化参数;根据所述变化参数、当前的第一治疗参数和预设的调整幅度,生成第二治疗参数,以及将所述第二治疗参数通过第二通信模块发送给智能化无损化光疗眼镜40中的透明LED脉冲光镜片401;所述第一治疗参数和所述第二治疗参数包括光照功率和光照频率;The processing module 501 in the remote operation terminal 50 generates the current change parameter of the patient's eye according to the obtained first eye information and the second eye information; treatment parameters and a preset adjustment range, generate second treatment parameters, and send the second treatment parameters to the transparent LED pulsed light lenses 401 in the intelligent nondestructive phototherapy glasses 40 through the second communication module; the first The treatment parameter and the second treatment parameter include illumination power and illumination frequency;

智能化无损化光疗眼镜40中的透明LED脉冲光镜片401根据接收到的所述第二治疗参数调整治疗光源的光照剂量。The transparent LED pulsed light lens 401 in the intelligent nondestructive phototherapy glasses 40 adjusts the light dose of the treatment light source according to the received second treatment parameter.

需要说明的是,远程操作终端50的承载实体可以是手机、平板、电脑,也可以是智能手表等各类智能穿戴产品。远程操作终端50的功能可以通过APP、小程序等多种方式实现。对于远程操作终端50的具体实现方式本文不作限制。It should be noted that the bearing entity of the remote operation terminal 50 may be a mobile phone, a tablet, a computer, or various smart wearable products such as a smart watch. The functions of the remote operation terminal 50 can be implemented in various ways such as APP, applet and the like. The specific implementation of the remote operation terminal 50 is not limited herein.

处理方法中的细节可以参考前文实施例,在此不再赘述。For details of the processing method, reference may be made to the foregoing embodiments, which will not be repeated here.

在本实施例中,相比智能化无损化光疗眼镜,光疗智能装置的调节使用更加方便,远程操作终端50可以承担更多的个性化功能设置,方便后期的功能拓展和产品升级。In this embodiment, compared with the intelligent lossless phototherapy glasses, the adjustment and use of the intelligent phototherapy device is more convenient, and the remote operation terminal 50 can undertake more personalized function settings, which is convenient for later function expansion and product upgrade.

本领域普通技术人员可以理解:附图只是一个实施例的示意图,附图中的模块或流程并不一定是实施本发明所必须的。Those skilled in the art can understand that the accompanying drawing is only a schematic diagram of an embodiment, and the modules or processes in the accompanying drawing are not necessarily necessary to implement the present invention.

本领域普通技术人员可以理解:实施例中的装置中的模块可以按照实施例描述分布于实施例的装置中,也可以进行相应变化位于不同于本实施例的一个或多个装置中。上述实施例的模块可以合并为一个模块,也可以进一步拆分成多个子模块。Those skilled in the art may understand that: the modules in the apparatus in the embodiment may be distributed in the apparatus in the embodiment according to the description of the embodiment, and may also be located in one or more apparatuses different from this embodiment with corresponding changes. The modules in the foregoing embodiments may be combined into one module, or may be further split into multiple sub-modules.

最后应说明的是:以上实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明实施例技术方案的精神和范围。Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, but not to limit them; although the present invention has been described in detail with reference to the foregoing embodiments, those of ordinary skill in the art should understand that it can still be The technical solutions described in the foregoing embodiments are modified, or some technical features thereof are equivalently replaced; and these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the spirit and scope of the technical solutions in the embodiments of the present invention.

Claims (7)

1.一种智能化无损光疗系统,其特征在于,所述光疗系统包括:监控模块、处理模块和光疗模块;1. an intelligent non-destructive phototherapy system, is characterized in that, described phototherapy system comprises: monitoring module, processing module and phototherapy module; 所述监控模块获取患者的第一眼部信息和第二眼部信息,将所述第一眼部信息和所述第二眼部信息发送给所述处理模块,所述第一眼部信息和所述第二眼部信息包括瞳孔大小、眼球血丝分布情况,所述第一眼部信息和所述第二眼部信息的获取时间间隔预设时间段;The monitoring module acquires the first eye information and the second eye information of the patient, and sends the first eye information and the second eye information to the processing module, and the first eye information and the second eye information are sent to the processing module. The second eye information includes pupil size and distribution of eyeballs, and the acquisition time interval of the first eye information and the second eye information is a preset time period; 所述处理模块根据获取到的所述第一眼部信息和所述第二眼部信息,生成所述患者眼部当前的变化参数;根据所述变化参数、当前的第一治疗参数和预设的调整幅度,生成第二治疗参数,以及将所述第二治疗参数发送给所述光疗模块;所述第一治疗参数和所述第二治疗参数包括光照功率和光照频率;The processing module generates the current change parameter of the patient's eye according to the obtained first eye information and the second eye information; according to the change parameter, the current first treatment parameter and the preset The adjustment amplitude of the second treatment parameter is generated, and the second treatment parameter is sent to the phototherapy module; the first treatment parameter and the second treatment parameter include illumination power and illumination frequency; 所述光疗模块根据接收到的所述第二治疗参数调整治疗光源的光照剂量。The light therapy module adjusts the light dose of the therapy light source according to the received second therapy parameter. 2.根据权利要求1所述的系统,其特征在于,所述第一眼部信息包括第一时刻的眼部信息和第二时刻的眼部信息,所述第二眼部信息包括第三时刻的眼部信息和第四时刻的眼部信息;2 . The system according to claim 1 , wherein the first eye information includes eye information at a first time and eye information at a second time, and the second eye information includes a third time. 3 . , and the eye information of the fourth moment; 所述处理模块根据获取到的所述第一眼部信息和所述第二眼部信息,生成所述患者眼部当前的变化参数的步骤,包括:The step of generating, by the processing module, the current change parameter of the patient's eye according to the acquired first eye information and the second eye information, includes: 所述处理模块根据所述第一时刻的眼部信息和第二时刻的眼部信息,生成患者的第一眼部信息;根据所述第三时刻的眼部信息和第四时刻的眼部信息,生成患者的第二眼部信息;The processing module generates the first eye information of the patient according to the eye information at the first moment and the eye information at the second moment; according to the eye information at the third moment and the eye information at the fourth moment , to generate the second eye information of the patient; 其中,所述第一时刻和所述第二时刻、所述第三时刻和所述第四时刻均间隔预设的第一时段,所述第二时刻和所述第三时刻间隔预设的第二时段。Wherein, the first time and the second time, the third time and the fourth time are all separated by a preset first time period, and the second time and the third time are separated by a preset first time period. Second period. 3.根据权利要求1所述的系统,其特征在于,所述第一眼部信息和第二眼部信息还包括眨眼频率;所述变化参数包括:瞳孔变量、眼球血丝分布密度变量和眨眼频率变量;第二治疗参数包括第三治疗参数和第四治疗参数;3. The system according to claim 1, wherein the first eye information and the second eye information further comprise blinking frequency; and the variation parameters include: pupil variable, eyeball capillary distribution density variable and blinking frequency variable; the second treatment parameter includes a third treatment parameter and a fourth treatment parameter; 所述根据所述变化参数、当前的第一治疗参数和预设的调整幅度,生成第二治疗参数的步骤,包括:The step of generating the second treatment parameter according to the change parameter, the current first treatment parameter and the preset adjustment range includes: 所述处理模块根据患者的瞳孔变化量、眼球血丝分布密度变化量和眨眼频率变化量,计算当前的适应度值;The processing module calculates the current fitness value according to the patient's pupil variation, eyeball blood capillary distribution density variation and blink frequency variation; 所述处理模块根据所述适应度值和预设的适应度值分区表,判断当前的所述第一治疗参数是否与所述患者匹配;The processing module determines whether the current first treatment parameter matches the patient according to the fitness value and a preset fitness value partition table; 若匹配,则所述处理模块基于所述第一治疗参数,上调预设的调整幅度,生成第三治疗参数;若不匹配,则所述处理模块根据所述第一治疗参数和预设的调整幅度,下调治疗参数,生成第四治疗参数。If it matches, the processing module increases a preset adjustment range based on the first treatment parameter to generate a third treatment parameter; if it does not match, the processing module adjusts according to the first treatment parameter and the preset adjustment. Amplitude, down-regulates the treatment parameter to generate a fourth treatment parameter. 4.根据权利要求3所述的系统,其特征在于,所述预设的适应度值分区表包括多个适应度值所在区间与评价的一一对应关系,所述评价包括适应、轻度不适应、不适应、严重不适应。4 . The system according to claim 3 , wherein the preset fitness value partition table includes a one-to-one correspondence between the intervals in which the plurality of fitness values are located and the evaluation, and the evaluation includes adaptation, mild discomfort, and mild discomfort. 5 . Adapted, unsuited, severely maladapted. 5.根据权利要求4所述的系统,其特征在于,所述所述处理模块根据所述第一治疗参数和预设的调整幅度,下调治疗参数,生成第四治疗参数的步骤,包括:5. The system according to claim 4, wherein the step of the processing module, according to the first treatment parameter and a preset adjustment range, down-regulates the treatment parameter, and generates a fourth treatment parameter, comprises: 若所述适应度值在所述预设的适应度值分区表中的评价为轻度不适应,则确定实际下调幅度为一倍的预设的调整幅度;若所述适应度值在所述预设的适应度值分区表中的评价为不适应,则确定实际下调幅度为两倍的预设的调整幅度;若所述适应度值在所述预设的适应度值分区表中的评价为严重不适应,则确定实际下调幅度为三倍的预设的调整幅度;If the evaluation of the fitness value in the preset fitness value partition table is slightly unsuitable, the actual adjustment range is determined to be one time of the preset adjustment range; if the fitness value is in the If the evaluation in the preset fitness value partition table is unsuitable, it is determined that the actual adjustment range is twice the preset adjustment range; if the fitness value is evaluated in the preset fitness value partition table For serious incompatibility, the actual adjustment range is determined to be three times the preset adjustment range; 在所述第一治疗参数的基础上,下调所述实际下调幅度,生成第四治疗参数。On the basis of the first treatment parameter, the actual down-regulation range is down-regulated to generate a fourth treatment parameter. 6.根据权利要求5所述的系统,其特征在于,所述评价还包括过敏;6. The system of claim 5, wherein the evaluation further comprises allergies; 在所述所述处理模块根据所述适应度值,在预设的适应度值分区表中找到对应的适应度值的评价的步骤之后,所述方法还包括:After the processing module finds the evaluation of the corresponding fitness value in the preset fitness value partition table according to the fitness value, the method further includes: 若评价为过敏,则所述处理模块向所述光疗模块发送停止治疗指令;If the evaluation is allergy, the processing module sends a stop treatment instruction to the light therapy module; 所述光疗模块在接收到所述停止治疗指令后,关闭所述治疗光源。The light therapy module turns off the therapy light source after receiving the stop therapy instruction. 7.根据权利要求1所述的系统,其特征在于,所述系统还包括调整模块;7. The system of claim 1, wherein the system further comprises an adjustment module; 所述调整模块获取第五治疗参数,将所述第五治疗参数发送给所述光疗模块;The adjustment module acquires a fifth treatment parameter, and sends the fifth treatment parameter to the phototherapy module; 所述光疗模块根据接收到的所述第五治疗参数对光源的光照剂量进行调整。The light therapy module adjusts the light dose of the light source according to the received fifth treatment parameter.
CN202210003888.9A 2022-01-05 2022-01-05 Intelligent nondestructive phototherapy system Active CN114392492B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210003888.9A CN114392492B (en) 2022-01-05 2022-01-05 Intelligent nondestructive phototherapy system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210003888.9A CN114392492B (en) 2022-01-05 2022-01-05 Intelligent nondestructive phototherapy system

Publications (2)

Publication Number Publication Date
CN114392492A true CN114392492A (en) 2022-04-26
CN114392492B CN114392492B (en) 2023-02-10

Family

ID=81229055

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210003888.9A Active CN114392492B (en) 2022-01-05 2022-01-05 Intelligent nondestructive phototherapy system

Country Status (1)

Country Link
CN (1) CN114392492B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117101017A (en) * 2023-10-08 2023-11-24 广州中科智慧健康产业科技有限公司 Personalized phototherapy room adjusting method and system based on biofeedback
CN119257911A (en) * 2024-10-21 2025-01-07 湖南赉拓物联网科技有限公司 A data analysis method and system for a comprehensive myopia and amblyopia treatment device

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6669651B1 (en) * 2000-02-24 2003-12-30 Matsushita Electric Works, Ltd. Non-invasive brain function examination
US20050256545A1 (en) * 2004-05-11 2005-11-17 Steve Koh System and method for evaluating heart failure using an implantable medical device based on heart rate during patient activity
UA77510U (en) * 2012-12-24 2013-02-11 Владимир Ильич Черний Method for assessing severity of preeclampsia in pregnant patients and efficacy of therapy in dynamics
CN104189997A (en) * 2014-07-25 2014-12-10 深圳市艾尔曼医疗电子仪器有限公司 Intelligent feedback high-potential therapeutic apparatus and therapeutic method
US20160374594A1 (en) * 2015-06-26 2016-12-29 Koninklijke Philips N.V. System for monitoring a dopaminergic activity
CN109965870A (en) * 2019-02-27 2019-07-05 杭州诺为医疗技术有限公司 A kind of method of automatic detection and stimulation therapy epilepsy
CN111414027A (en) * 2020-04-30 2020-07-14 厦门中翎易优创科技有限公司 A thermotherapy device with automatic temperature adjustment
CN113181016A (en) * 2021-05-13 2021-07-30 云南白药集团无锡药业有限公司 Eye adjustment training lamp with dynamically-changed illumination
CN113693612A (en) * 2021-08-16 2021-11-26 深圳大学 Senile dementia diagnosis and treatment device
CN113713256A (en) * 2021-09-03 2021-11-30 重庆极治医疗科技有限公司 Electric field cancer treatment equipment with feedback mechanism and diagnosis function and method

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6669651B1 (en) * 2000-02-24 2003-12-30 Matsushita Electric Works, Ltd. Non-invasive brain function examination
US20050256545A1 (en) * 2004-05-11 2005-11-17 Steve Koh System and method for evaluating heart failure using an implantable medical device based on heart rate during patient activity
UA77510U (en) * 2012-12-24 2013-02-11 Владимир Ильич Черний Method for assessing severity of preeclampsia in pregnant patients and efficacy of therapy in dynamics
CN104189997A (en) * 2014-07-25 2014-12-10 深圳市艾尔曼医疗电子仪器有限公司 Intelligent feedback high-potential therapeutic apparatus and therapeutic method
US20160374594A1 (en) * 2015-06-26 2016-12-29 Koninklijke Philips N.V. System for monitoring a dopaminergic activity
CN109965870A (en) * 2019-02-27 2019-07-05 杭州诺为医疗技术有限公司 A kind of method of automatic detection and stimulation therapy epilepsy
CN111414027A (en) * 2020-04-30 2020-07-14 厦门中翎易优创科技有限公司 A thermotherapy device with automatic temperature adjustment
CN113181016A (en) * 2021-05-13 2021-07-30 云南白药集团无锡药业有限公司 Eye adjustment training lamp with dynamically-changed illumination
CN113693612A (en) * 2021-08-16 2021-11-26 深圳大学 Senile dementia diagnosis and treatment device
CN113713256A (en) * 2021-09-03 2021-11-30 重庆极治医疗科技有限公司 Electric field cancer treatment equipment with feedback mechanism and diagnosis function and method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
魏勋斌等: "神经退行性疾病的光学疗法及其应用展望", 《中国工程科学》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117101017A (en) * 2023-10-08 2023-11-24 广州中科智慧健康产业科技有限公司 Personalized phototherapy room adjusting method and system based on biofeedback
CN119257911A (en) * 2024-10-21 2025-01-07 湖南赉拓物联网科技有限公司 A data analysis method and system for a comprehensive myopia and amblyopia treatment device

Also Published As

Publication number Publication date
CN114392492B (en) 2023-02-10

Similar Documents

Publication Publication Date Title
US20200121544A1 (en) Systems and methods for treating neurological disorders
CN110913951B (en) System and method for stimulating optic nerve
US10962789B1 (en) Digital eyewear system and method for the treatment and prevention of migraines and photophobia
US11982815B2 (en) Light control devices and methods for regional variation of visual information and sampling
TWI889836B (en) Projection of defocused images on the peripheral retina to treat refractive error
US10386646B1 (en) Light control devices and methods for regional variation of visual information and sampling
CN114392492B (en) Intelligent nondestructive phototherapy system
WO2019153968A1 (en) Method and apparatus for configuring and regulating light emission parameters of biological rhythm illumination apparatus
US7455408B2 (en) Method and apparatus for reducing visual aberrations
CN112807544A (en) Acousto-optic intelligent control system for auxiliary treatment of Alzheimer's disease and implementation device
KR20130104978A (en) Tinnitus treating apparatus and method for stimulaitng of hair cell
CN218010658U (en) Intelligent lossless phototherapy glasses
CN114392496B (en) An acousto-optic intelligent non-destructive bone conduction therapy system
CN115554112A (en) Visual training methods to improve eyesight
US20190321582A1 (en) Method and Device for Controlling Electrical Stimulation Therapeutic Apparatus
CN105287091A (en) Wearable apparatus for treating myopia
Pudden et al. Holistic Perspectives on Older Persons’ Needs, Part 1: Cognition, Hearing, Vision, Sleep, and Rest
Younan et al. Evolving Strategies in Amblyopia Management: From Traditional Therapies to Cutting-Edge Innovations
Vision It causes progressive peripheral visual field loss and is often otherwise asymptomatic. First-degree relatives over 40 years old of someone with glaucoma are entitled to free eye tests in some countries
WO2025104252A1 (en) System, spectacle frame, computer-implemented method, and computer program for controlling a progression of myopia in at least one eye of a person
WO2024084303A1 (en) Sensory medical device with expanded features
HK40022771A (en) System to stimulate the optic nerve

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant